Form 8-K - Current report:
SEC Accession No. 0001682852-25-000036
Filing Date
2025-05-05
Accepted
2025-05-05 16:03:04
Documents
13
Period of Report
2025-04-30
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K mrna-20250430.htm   iXBRL 8-K 40233
  Complete submission text file 0001682852-25-000036.txt   163664

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mrna-20250430.xsd EX-101.SCH 1788
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mrna-20250430_lab.xml EX-101.LAB 21629
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mrna-20250430_pre.xml EX-101.PRE 12512
15 EXTRACTED XBRL INSTANCE DOCUMENT mrna-20250430_htm.xml XML 2803
Mailing Address 325 BINNEY STREET CAMBRIDGE MA 02142
Business Address 325 BINNEY STREET CAMBRIDGE MA 02142 6177146500
Moderna, Inc. (Filer) CIK: 0001682852 (see all company filings)

EIN.: 813467528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38753 | Film No.: 25912795
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)